Jubilant Ingrevia Limited signed a Share Purchase Agreement to acquire 100% equity stake in Remidex Pharma Private Limited for Rs 16.5 crore cash consideration, making it a wholly owned subsidiary.

Bangalore-based Remidex, incorporated June 15, 1981, manufactures micronutrient premixes, nutraceuticals, and serves as contract manufacturer for Indian/multinational pharma firms. FY25 turnover Rs 24.27 crore with WHO-GMP, FSSC, FSSAI certified facility.

The non-related party acquisition advances Jubilant Ingrevia up the human nutrition value chain from vitamins (B3, B4) leadership into premixes, targeting completion within 30 days.